ATC codes: V03AC01
Other specified sickle cell disorders or other haemoglobinopathies ICD11 code: 3A51.Y
Parenteral > General injections > unspecified: 500 mg in vial powder for injection (mesilate)
Also recommended for children
Patents have expired in most jurisdictions
Read more about patents.
Summary of evidence and Expert Committee recommendations
Following the review of square box listings on the EML and EMLc, the Expert Committee recommended oral deferasirox be specified as a therapeutic alternative under the square box listing for deferoxamine on the EML and EMLc for this indication.